Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Medical Genetics
Published in: BMC Medical Genetics 1/2006

Open Access 01-12-2006 | Research article

Effect of Native American ancestry on iron-related phenotypes of Alabama hemochromatosis probands with HFEC282Y homozygosity

Authors: James C Barton, Ellen H Barton, Ronald T Acton

Published in: BMC Medical Genetics | Issue 1/2006

Login to get access

Abstract

Background

In age-matched cohorts of screening study participants recruited from primary care clinics, mean serum transferrin saturation values were significantly lower and mean serum ferritin concentrations were significantly higher in Native Americans than in whites. Twenty-eight percent of 80 Alabama white hemochromatosis probands with HFE C282Y homozygosity previously reported having Native American ancestry, but the possible effect of this ancestry on hemochromatosis phenotypes was unknown.

Methods

We compiled observations in these 80 probands and used univariate and multivariate methods to analyze associations of age, sex, Native American ancestry (as a dichotomous variable), report of ethanol consumption (as a dichotomous variable), percentage transferrin saturation and loge serum ferritin concentration at diagnosis, quantities of iron removed by phlebotomy to achieve iron depletion, and quantities of excess iron removed by phlebotomy.

Results

In a univariate analysis in which probands were grouped by sex, there were no significant differences in reports of ethanol consumption, transferrin saturation, loge serum ferritin concentration, quantities of iron removed to achieve iron depletion, and quantities of excess iron removed by phlebotomy in probands who reported Native American ancestry than in those who did not. In multivariate analyses, transferrin saturation (as a dependent variable) was not significantly associated with any of the available variables, including reports of Native American ancestry and ethanol consumption. The independent variable quantities of excess iron removed by phlebotomy was significantly associated with loge serum ferritin used as a dependent variable (p < 0.0001), but not with reports of Native American ancestry or reports of ethanol consumption. Loge serum ferritin was the only independent variable significantly associated with quantities of excess iron removed by phlebotomy used as a dependent variable (p < 0.0001) (p < 0.0001; ANOVA of regression).

Conclusion

We conclude that the iron-related phenotypes of hemochromatosis probands with HFE C282Y homozygosity are similar in those with and without Native American ancestry reports.
Literature
1.
Deugnier Y, Jouanolle AM, Chaperon J, Moirand R, Pithois C, Meyer JF, Pouchard M, Lafraise B, Brigand A, Caserio-Schoenemann C, Mosser J, Adams P, le Gall JY, David V: Gender-specific phenotypic expression and screening strategies in C282Y-linked haemochromatosis: a study of 9396 French people. Br J Haematol. 2002, 118: 1170-1178. 10.1046/j.1365-2141.2002.03718.x.CrossRefPubMed
2.
Barton JC, Barton NH, Alford TJ: Diagnosis of hemochromatosis probands in a community hospital. Am J Med. 1997, 103: 498-503. 10.1016/S0002-9343(97)00276-3.CrossRefPubMed
3.
Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH, McLaren GD, Dawkins FW, Acton RT, Harris EL, Gordeuk VR, Leiendecker-Foster C, Speechley M, Snively BM, Holup JL, Thomson E, Sholinsky P: Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med. 2005, 352: 1769-1778. 10.1056/NEJMoa041534.CrossRefPubMed
4.
Asberg A, Hveem K, Thorstensen K, Ellekjter E, Kannelonning K, Fjosne U, Halvorsen TB, Smethurst HB, Sagen E, Bjerve KS: Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65,238 persons. Scand J Gastroenterol. 2001, 36: 1108-1115. 10.1080/003655201750422747.CrossRefPubMed
5.
Waalen J, Felitti V, Gelbart T, Ho NJ, Beutler E: Penetrance of hemochromatosis. Blood Cells Mol Dis. 2002, 29: 418-432. 10.1006/bcmd.2002.0596.CrossRefPubMed
6.
Waalen J, Nordestgaard BG, Beutler E: The penetrance of hereditary hemochromatosis. Best Pract Res Clin Haematol. 2005, 18: 203-220. 10.1016/j.beha.2004.08.023.CrossRefPubMed
7.
Jacolot S, Le Gac G, Scotet V, Quere I, Mura C, Ferec C: HAMP as a modifier gene that increases the phenotypic expression of the HFE pC282Y homozygous genotype. Blood. 2004, 103: 2835-2840. 10.1182/blood-2003-10-3366.CrossRefPubMed
8.
Le Gac G, Scotet V, Ka C, Gourlaouen I, Bryckaert L, Jacolot S, Mura C, Ferec C: The recently identified type 2A juvenile haemochromatosis gene (HJV), a second candidate modifier of the C282Y homozygous phenotype. Hum Mol Genet. 2004, 13: 1913-1918. 10.1093/hmg/ddh206.CrossRefPubMed
9.
Merryweather-Clarke AT, Cadet E, Bomford A, Capron D, Viprakasit V, Miller A, McHugh PJ, Chapman RW, Pointon JJ, Wimhurst VL, Livesey KJ, Tanphaichitr V, Rochette J, Robson KJ: Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis. Hum Mol Genet. 2003, 12: 2241-2247. 10.1093/hmg/ddg225.CrossRefPubMed
10.
Cook JD: Hemochromatosis: effect of iron fortification of foods. Hemochromatosis: genetics, pathophysiology, diagnosis and treatment. Edited by: Barton JC and Edwards CQ. 2000, Cambridge, Cambridge University Press, 535-543.CrossRef
11.
Chan AT, Ma J, Tranah GJ, Giovannucci EL, Rifai N, Hunter DJ, Fuchs CS: Hemochromatosis gene mutations, body iron stores, dietary iron, and risk of colorectal adenoma in women. J Natl Cancer Inst. 2005, 97: 917-926.CrossRefPubMed
12.
Carter K, Bowen DJ, McCune CA, Worwood M: Haptoglobin type neither influences iron accumulation in normal subjects nor predicts clinical presentation in HFE C282Y haemochromatosis: phenotype and genotype analysis. Br J Haematol. 2003, 122: 326-332. 10.1046/j.1365-2141.2003.04436.x.CrossRefPubMed
13.
Beutler E, Gelbart T, Lee P: Haptoglobin polymorphism and iron homeostasis. Clin Chem. 2002, 48: 2232-2235.PubMed
14.
Barton JC, Wiener HW, Acton RT, Go RC: HLA haplotype A*03-B*07 in hemochromatosis probands with HFE C282Y homozygosity: frequency disparity in men and women and lack of association with severity of iron overload. Blood Cells Mol Dis. 2005, 34: 38-47. 10.1016/j.bcmd.2004.08.022.CrossRefPubMed
15.
Beutler E, Beutler L, Lee PL, Barton JC: The mitochondrial nt 16189 polymorphism and hereditary hemochromatosis. Blood Cells Mol Dis. 2004, 33: 344-345. 10.1016/j.bcmd.2004.06.006.CrossRefPubMed
16.
Beutler E, Gelbart T: Tumor necrosis factor alpha promoter polymorphisms and liver abnormalities of homozygotes for the 845G>A(C282Y) hereditary hemochromatosis mutation. Blood. 2002, 100: 2268-2269. 10.1182/blood-2002-05-1520.CrossRefPubMed
17.
Lee PL, Ho NJ, Olson R, Beutler E: The effect of transferrin polymorphisms on iron metabolism. Blood Cells Mol Dis. 1999, 25: 374-379. 10.1006/bcmd.1999.0267.CrossRefPubMed
18.
Lee PL, Gelbart T, West C, Halloran C, Felitti V, Beutler E: A study of genes that may modulate the expression of hereditary hemochromatosis: transferrin receptor-1, ferroportin, ceruloplasmin, ferritin light and heavy chains, iron regulatory proteins (IRP)-1 and -2, and hepcidin. Blood Cells Mol Dis. 2001, 27: 783-802. 10.1006/bcmd.2001.0445.CrossRefPubMed
19.
Lee PL, Barton JC, Brandhagen D, Beutler E: Hemojuvelin (HJV) mutations in persons of European, African-American and Asian ancestry with adult onset haemochromatosis. Br J Haematol. 2004, 127: 224-229. 10.1111/j.1365-2141.2004.05165.x.CrossRefPubMed
20.
Tsuchihashi Z, Hansen SL, Quintana L, Kronmal GS, Mapa FA, Feder JN, Wolff RK: Transferrin receptor mutation analysis in hereditary hemochromatosis patients. Blood Cells Mol Dis. 1998, 24: 317-321. 10.1006/bcmd.1998.0199.CrossRefPubMed
21.
Barton JC, Acton RT, Lovato L, Speechley MR, McLaren CE, Harris EL, Reboussin DM, Adams PC, Dawkins FW, Gordeuk VR, Walker AP: Initial Screening Transferrin Saturation Values, Serum Ferritin Concentrations, and HFE Genotypes in Native Americans and Whites in the Hemochromatosis and Iron Overload Screening (HEIRS) Study. Clin Genet. 2006, 69: 48-10.1111/j.1399-0004.2006.00553.x.CrossRefPubMed
22.
Barton EH, Barton JC, Hollowell WW, Acton RT: Countries of ancestry reported by hemochromatosis probands and control subjects in central Alabama. Ethnicity and Disease. 2004, 14: 73-81.PubMed
23.
Barton JC, Acton RT: Inheritance of two HFE mutations in African Americans: cases with hemochromatosis phenotypes and estimates of hemochromatosis phenotype frequency. Genetics in Medicine. 2001, 3: 294-300. 10.1097/00125817-200107000-00005.CrossRefPubMed
24.
Barton JC, Edwards CQ, Bertoli LF, Shroyer TW, Hudson SL: Iron overload in African Americans. American Journal of Medicine. 1995, 99: 616-623. 10.1016/S0002-9343(99)80248-4.CrossRefPubMed
25.
Barton JC, Acton RT, Rivers CA, Bertoli LF, Gelbart T, West C, Beutler E: Genotypic and phenotypic heterogeneity of African Americans with primary iron overload. Blood Cells Mol Dis. 2003, 31: 310-319. 10.1016/S1079-9796(03)00166-9.CrossRefPubMed
26.
27.
Barton JC, Shih WW, Sawada-Hirai R, Acton RT, Harmon L, Rivers C, Rothenberg BE: Genetic and clinical description of hemochromatosis probands and heterozygotes: evidence that multiple genes linked to the major histocompatibility complex are responsible for hemochromatosis. Blood Cells Mol Dis. 1997, 23: 135-145. 10.1006/bcmd.1997.0129.CrossRefPubMed
28.
Barton JC, Felitti VJ, Lee P, Beutler E: Characteristics of HFE C282Y homozygotes younger than age 30 years. Acta Haematol. 2004, 112: 219-221. 10.1159/000081277.CrossRefPubMed
29.
Hicken BL, Tucker DC, Barton JC: Patient compliance with phlebotomy therapy for iron overload associated with hemochromatosis. Am J Gastroenterol. 2003, 98: 2072-2077. 10.1111/j.1572-0241.2003.07292.x.CrossRefPubMed
30.
McLaren CE, Barton JC, Adams PC, Harris EL, Acton RT, Press N, Reboussin DM, McLaren GD, Sholinsky P, Walker AP, Gordeuk VR, Leiendecker-Foster C, Dawkins FW, Eckfeldt JH, Mellen BG, Speechley M, Thomson E: Hemochromatosis and Iron Overload Screening (HEIRS) study design for an evaluation of 100,000 primary care-based adults. Am J Med Sci. 2003, 325: 53-62. 10.1097/00000441-200302000-00001.CrossRefPubMed
31.
Box GEP, Cox DR: An analysis of transformations. J Royal Stat Soc Series B (Methodological). 1964, 26: 211-252.
32.
Phatak PD, Barton JC: Phlebotomy-mobilized iron as a surrogate for liver iron content in hemochromatosis patients. Hematology. 2003, 8: 429-432. 10.1080/1024533032000158832.CrossRefPubMed
33.
Beutler E, Felitti V, Ho NJ, Gelbart T: Relationship of body iron stores to levels of serum ferritin, serum iron, unsaturated iron binding capacity and transferrin saturation in patients with iron storage disease. Acta Haematol. 2002, 107: 145-149. 10.1159/000057632.CrossRefPubMed
34.
Bell H, Skinningsrud A, Raknerud N, Try K: Serum ferritin and transferrin saturation in patients with chronic alcoholic and non-alcoholic liver diseases. J Intern Med. 1994, 236: 315-322.CrossRefPubMed
35.
Moirand R, Lescoat G, Delamaire D, Lauvin L, Campion JP, Deugnier Y, Brissot P: Increase in glycosylated and nonglycosylated serum ferritin in chronic alcoholism and their evolution during alcohol withdrawal. Alcohol Clin Exp Res. 1991, 15: 963-969.CrossRefPubMed
36.
Southerland HLJ, Brown JE: The Federal Road through Georgia, the Creek Nation, and Alabama, 1806-1836. 1989, Tuscaloosa, The University of Alabama Press, 1-198.
37.
Williams WL: Ethnic Life. Cherokees. Encyclopedia of Southern Culture. Edited by: Wilson CR and Ferris W. 1989, Chapel Hill, The University of North Carolina Press, 423-424.
38.
Paredes JA: Ethnic Life. Creeks. Encyclopedia of Southern Culture. Edited by: Wilson CR and Ferris W. 1989, Chapel Hill, The University of North Carolina Press, 426-
39.
Pickett AJ: History of Alabama and Incidentally of Georgia and Mississippi, from the Earliest Period. 1851. Edited by: Alabama CODCUSMD. 1961, Birmingham, Birmingham Book and Magazine Co. (republisher), XII. : 1-685. Clerk's Office of the District Court of the United States for the Middle District of Alabama.
40.
Alabama State Department of Archives and History: Alabama Census Returns 1820 and An Abstract of Federal Census of Alabama 1830. Alabama Historical Quarterly. 1944, Fall Issue: 333-513.
41.
42.
43.
Witte DL, Crosby WH, Edwards CQ, Fairbanks VF, Mitros FA: Practice guideline development task force of the College of American Pathologists. Hereditary hemochromatosis. Clin Chim Acta. 1996, 245: 139-200. 10.1016/0009-8981(95)06212-2.CrossRefPubMed
44.
45.
Fargion S, Mattioli M, Fracanzani AL, Sampietro M, Tavazzi D, Fociani P, Taioli E, Valenti L, Fiorelli G: Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis. Am J Gastroenterol. 2001, 96: 2448-2455. 10.1111/j.1572-0241.2001.04052.x.CrossRefPubMed
46.
Di Bisceglie AM, Axiotis CA, Hoofnagle JH, Bacon BR: Measurements of iron status in patients with chronic hepatitis. Gastroenterology. 1992, 102: 2108-2113.CrossRefPubMed
47.
Kowdley KV: Chronic viral hepatitis and hemochromatosis. Hemochromatosis. Genetics, pathophysiology, diagnosis and treatment. Edited by: Barton JC and Edwards CQ. 2000, Cambridge, Cambridge University Press, 387-395.CrossRef
48.
Whitfield JB, Cullen LM, Jazwinska EC, Powell LW, Heath AC, Zhu G, Duffy DL, Martin NG: Effects of HFE C282Y and H63D polymorphisms and polygenic background on iron stores in a large community sample of twins. Am J Hum Genet. 2000, 66: 1246-1258. 10.1086/302862.CrossRefPubMedPubMedCentral
49.
Rossi E, Bulsara MK, Olynyk JK, Cullen DJ, Summerville L, Powell LW: Effect of hemochromatosis genotype and lifestyle factors on iron and red cell indices in a community population. Clin Chem. 2001, 47: 202-208.PubMed
50.
Harlow SD, Campbell B: Ethnic differences in the duration and amount of menstrual bleeding during the postmenarcheal period. Am J Epidemiol. 1996, 144: 980-988.CrossRefPubMed
51.
Borwein ST, Ghent CN, Flanagan PR, Chamberlain MJ, Valberg LS: Genetic and phenotypic expression of hemochromatosis in Canadians. Clin Invest Med. 1983, 6: 171-179.PubMed
Metadata
Title
Effect of Native American ancestry on iron-related phenotypes of Alabama hemochromatosis probands with HFEC282Y homozygosity
Authors
James C Barton
Ellen H Barton
Ronald T Acton
Publication date
01-12-2006
Publisher
BioMed Central
Published in
BMC Medical Genetics / Issue 1/2006
Electronic ISSN: 1471-2350
DOI
https://doi.org/10.1186/1471-2350-7-22

Other articles of this Issue 1/2006

BMC Medical Genetics 1/2006 Go to the issue

Research article

Three novel and the common Arg677Ter RP1 protein truncating mutations causing autosomal dominant retinitis pigmentosa in a Spanish population

Research article

Breakpoint Associated with a novel 2.3 Mb deletion in the VCFS region of 22q11 and the role of Alu (SINE) in recurring microdeletions

Research article

Identification of novel functional sequence variants in the gene for peptidase inhibitor 3

Research article

The quantification of COMT mRNA in post mortem cerebellum tissue: diagnosis, genotype, methylation and expression

Research article

Influence of advanced age of maternal grandmothers on Down syndrome

Research article

Interleukin-10 haplotypes in Celiac Disease in the Spanish population